Literature DB >> 25504922

Repeated STI and HIV testing among HIV-negative men who have sex with men attending a large STI clinic in Amsterdam: a longitudinal study.

Henrike J Vriend1, Ineke G Stolte2, Janneke C M Heijne3, Titia Heijman4, Henry J C De Vries5, Ronald B Geskus6, Marianne A B Van der Sande7, Maria Prins2.   

Abstract

OBJECTIVE: In the Netherlands, men who have sex with men (MSM) are advised via informal guidelines to test for STI at least annually. We estimated the proportion of HIV-negative MSM testing repeatedly at 12-month or smaller intervals at a large STI clinic in the Netherlands. In addition, we explored whether repeated testing is related to risk behaviour. DESIGN AND METHODS: Longitudinal data of HIV-negative MSM visiting the Amsterdam STI clinic between 2009 and 2012 were analysed. To estimate the timing of repeated testing, Kaplan-Meier methods were used. Determinants for repeated testing (distinguishing testing at 12-month or smaller intervals and less than 12-monthly testing, with single testers as reference group) were identified using multivariate multinomial logistic regression analyses.
RESULTS: In total, 19,479 consultations of 9174 HIV-negative MSM were identified. Of these MSM, 35% (95% CI 33% to 36%) were estimated to return to the STI clinic within 1 year following baseline consultation. Among 1767 men with at least two consultations and at least 2 years between baseline and last consultation, 43% tested repeatedly at 12-month or smaller intervals in those first 2 years. Repeated testers reported higher sexual risk behaviour (ie, only casual or both casual and steady sex partners, higher numbers of sex partners) at baseline compared with single testers. This effect tended to be slightly stronger for men testing repeatedly at 12-month or smaller intervals.
CONCLUSIONS: The proportion of MSM testing for STI annually is low. MSM testing repeatedly had higher baseline levels of risk behaviour. Strategies to motivate MSM to test annually should be explored. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  GUIDELINE DEVELOPMENT; HOMOSEXUALITY; TESTING

Mesh:

Year:  2014        PMID: 25504922     DOI: 10.1136/sextrans-2014-051786

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Repeat HIV testing among HIV-uninfected men who have sex with men attending Silom Community Clinic, Bangkok, 2011 - 2014.

Authors:  Wipas Wimonsate; Sarika Pattanasin; Chaiwat Ungsedhapand; Kanokpan Pancharoen; Pikunchai Luechai; Kesinee Satumay; Santi Winaitham; Wichuda Sukwicha; Pachara Sirivongrangsan; Eileen F Dunne; Timothy H Holtz
Journal:  Int J STD AIDS       Date:  2018-08-16       Impact factor: 1.359

2.  Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016.

Authors:  Ard van Sighem; Anastasia Pharris; Chantal Quinten; Teymur Noori; Andrew J Amato-Gauci
Journal:  Euro Surveill       Date:  2017-11

3.  Repeat Chlamydia trachomatis testing among heterosexual STI outpatient clinic visitors in the Netherlands: a longitudinal study.

Authors:  Maartje Visser; Fleur van Aar; Femke D H Koedijk; Carolina J G Kampman; Janneke C M Heijne
Journal:  BMC Infect Dis       Date:  2017-12-20       Impact factor: 3.090

4.  Frequency and determinants of consistent STI/HIV testing among men who have sex with men testing at STI outpatient clinics in the Netherlands: a longitudinal study.

Authors:  Maartje Visser; Janneke C M Heijne; Arjan A Hogewoning; Fleur van Aar
Journal:  Sex Transm Infect       Date:  2017-02-03       Impact factor: 3.519

5.  Determinants of frequent and infrequent STI testing and STI diagnosis related to test frequency among men who have sex with men in the eastern part of the Netherlands: a 6-year retrospective study.

Authors:  Carolina J G Kampman; Janneke C M Heijne; Petronella H M Kistemaker-Koedijk; Femke D H Koedijk; Maartje Visser; Jeannine L A Hautvast
Journal:  BMJ Open       Date:  2018-05-31       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.